Articles from APA

Share this post - Florida Baptist Witness

Florida Baptist WitnessShare this postFlorida Baptist WitnessThe American Psychiatric Association, wh

Actelion to enter Phase II clinical development with new dual orexin receptor antagonist in patients with insomnia - Yahoo Finance

Actelion to enter Phase II clinical development with new dual orexin receptor antagonist in patients with insomniaYahoo FinanceALLSCHWIL, SWITZERLAND - 07 July 2016 - Actelion Ltd (ATLN.VX) announced today that the company is initiating a Phase II program with its new dual orexin receptor antagonist (

Pages